Bailey DL, Willowson KP. An evidence-based review of quantitative SPECT imaging and potential clinical applications. J Nucl Med. 2013;54(1):83–9.
Capoccetti F, Biggi E, Rossi G, Manni C, Brianzoni E. Differentiated thyroid carcinoma: diagnosis and dosimetry using 124I PET/CT. Clin Transl Imaging. 2013;1(3):185–93.
Liu T, Karlsen M, Karlberg AM, Redalen KR. Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms. EJNMMI Res. 2020;10(1):33.
Article PubMed PubMed Central Google Scholar
Blaire T, Bailliez A, Ben Bouallegue F, Bellevre D, Agostini D, Manrique A. First assessment of simultaneous dual isotope (123I/99mTc) cardiac SPECT on two different CZT cameras: a phantom study. J Nucl Cardiol. 2018;25(5):1692–704.
Dewaraja YK, et al. MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications. J Nucl Med. 2013;54(12):2182–8.
Article CAS PubMed Google Scholar
Ljungberg M, Celler A, Konijnenberg MW, Eckerman KF, Dewaraja YK, Sjögreen-Gleisner K. MIRD pamphlet no. 26: Joint EANM/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy. J Nucl Med. 2016;57(1):151–62.
Article CAS PubMed Google Scholar
Brady SL, and Shulkin BL. Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma. EJNMMI Phys. 2019;6(1):31
Dittmann H et al. The prognostic value of quantitative bone scan SPECT/CT prior to 223 Ra treatment in metastatic castration-resistant prostate cancer. J Nucl Med. 2021;62(1):48–54.
De Laroche R, et al. Clinical interest of quantitative bone SPECT-CT in the preoperative assessment of knee osteoarthritis. Medicine (Baltimore). 2018;97(35):e11943.
Jreige M et al. A novel assessment of Tc-99m-diphosphonate bone scan quantification in fibrous dysplasia using a combined planar and SPECT/CT analysis. J Nucl Med. 2021;62(supplement 1):1164
Umeda T, et al. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients. Ann Nucl Med. 2018;32(2):105–13.
Article CAS PubMed Google Scholar
Van De Burgt A et al. Experimental validation of absolute SPECT/ CT quantification for response monitoring in patients with coronary artery disease. EJNMMI Phys. 2021;8(1):48
Toriihara A, et al. Semiquantitative analysis using standardized uptake value in 123I-FP-CIT SPECT/CT. Clin Imaging. 2018;52:57–61.
Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(SUPPL. 1):122–50.
Sher A, et al. For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time. EJNMMI Res. 2016;6(1):4–9.
Kaalep A, et al. Feasibility of state of the art PET/CT systems performance harmonisation. Eur J Nucl Med Mol Imaging. 2018;43(Suppl 1):189.
American Association of Physics in Medicine. The selection, use, calibration, and quality assurance of radionuclide calibrators used in nuclear medicine. Report of AAPM task group 181. Maryland 2012. https://doi.org/10.37206/137.
International Atomic Energy Agency. Tech Report Series no. 454. Quality assurance for radioactivity measurement in nuclear medicine. Vienna 2006. Available online at https://www.iaea.org/publications/7480/quality-assurance-for-radioactivity-measurement-in-nuclear-medicine. Accessed 5 Oct 2022.
Lassmann M, Eberlein U, Tran-Gia J. Multicentre trials on standardised quantitative imaging and dosimetry for radionuclide therapies. Clin Oncol. 2021;33(2):125–30.
Saldarriaga Vargas C et al. An international multi-center investigation on the accuracy of radionuclide calibrators in nuclear medicine theragnostics, EJNMMI Phys. 2020;7(1):69
Busemann Sokole E, Płachcínska A, Britten A. Acceptance testing for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging. 2010;3:672–81.
Gadd R et al. Protocol for establishing and maintaining the calibration of medical radionuclide calibrators and their quality control. Measurement good practice guide No.93. National Physical Laboratory, Teddington 2006. Available online at: https://eprintspublications.npl.co.uk/3661/. Accessed 5 Oct 2022.
Dewaraja YK, et al. MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy. J of Nucl Med. 2012;53(8):310–1325.
Tran-Gia J et al. A multicentre and multi-national evaluation of the accuracy of quantitative Lu-177 SPECT/CT imaging performed within the MRTDosimetry project. EJNMMI Phys. 2021;8(1):55
Kaalep A et al. Quantitative implications of the updated EARL 2019 PET–CT performance standards. EJNMMI Phys. 2019;6(1):28
Budinger TF, Derenzo SE, Greenberg WL, Gullberg GT, Huesman RH. Quantitative potentials of dynamic emission computed tomography. J Nucl Med. 1978;19(3):309–15.
Dickson JC, et al. The impact of reconstruction method on the quantification of DaTSCAN images. Eur J Nucl Med Mol Imaging. 2010;37(1):23–35.
Armstrong IS. Spatial dependence of activity concentration recovery for a conjugate gradient (Siemens xSPECT) algorithm using manufacturer-defined reconstruction presets. Nucl Med Commun. 2019;40(3):287–93.
Blankespoor SC, et al. Attenuation correction of SPECT using X-ray CT on an emission-transmission CT system: myocardial perfusion assessment. IEEE Trans Nucl Sci. 1996;43(4):2263–74.
Abdoli M, Dierckx RAJO, Zaidi H. Metal artifact reduction strategies for improved attenuation correction in hybrid PET/CT imaging. Med Phys. 2012;39(6):3343–60.
Konishi T, et al. Metal artifact reduction for improving quantitative SPECT/CT imaging. Ann Nucl Med. 2021;35(3):291–8.
Article CAS PubMed Google Scholar
Hutton BF, Buvat I, Beekman FJ. Review and current status of SPECT scatter correction. Phys Med Biol. 2011;56(14):R85-112.
Liu S, and Farncombe TH. Collimator-detector response compensation in quantitative SPECT reconstruction. 2007 IEEE Nuclear Science Symposium Conference Record 5 2007:3955–60.
Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39(5):904–11.
The European Parliament and the Council of the European Union, Regulation (EU) 2017/ 745 of the European Parliament and of the council - of 5 April 2017 - on medical devices, amending Directive 2001/ 83/ EC, Regulation (EC) No 178/ 2002 and Regulation (EC) No 1223/ 2009 and repealing Council Directives 90/ 385/ EEC and 93/ 42/ EEC. 2017. Available online at https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0745. Accessed 5 Oct 2022.
Buckley SE et al. Dosimetry for fractionated 131 I-mIBG therapies in patients with primary resistant high-risk neuroblastoma: preliminary results, CANCER Biother. Radiopharm. 2007;22(1):105–12.
Desy A, Bouvet GF, Frezza A, Després P, and Beauregard J-M. Impact of dead time on quantitative 177 Lu-SPECT (QSPECT) and kidney dosimetry during PRRT. EJNMMI Phys. 2020;7(1):32.
Gear J, Chiesa C, Lassmann M, Gabiña PM, Tran-Gia J, and Stokke C. EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131 I mIBG treatment of neuroendocrine tumours Glenn Flux 1 and In collaboration with the EANM Dosimetry Committee, EJNMMI Phys. 2020;7(1):15
Busemann Sokole E, Płachcínska A, Britten A, Lyra Georgosopoulou M, Tindale W, Klett R. Routine quality control recommendations for nuclear medicine instrumentation. Eur J Nucl Med Mol Imaging. 2010;37(3):662–71.
Tatsch K. Standardisation and harmonisation boost the credibility of nuclear medicine procedures. Eur J Nucl Med Mol Imaging. 2012;39(1):186–7.
Zimmerman BE, Judge S. Traceability in nuclear medicine. Metrologia. 2007;44(4):S127–32.
BIPM, IEC, IFCC, ILAC, IUPAC, IUPAP, ISO, OIML The international vocabulary of metrology—basic and general concepts and associated terms (VIM) 2012, 3rd edn. JCGM 200:2012 Available online at http://www.bipm.org/vim. Accessed 5 Oct 2022.
Kaalep A, et al. EANM/EARL FDG-PET/CT accreditation—summary results from the first 200 accredited imaging systems. Eur J Nucl Med Mol Imaging. 2018;45(3):412–22.
Article CAS PubMed Google Scholar
Hughes T, Celler A. A multivendor phantom study comparing the image quality produced from three state-of-the-art SPECT-CT systems. Nucl Med Commun. 2012;33(6):663–70.
Nakahara T, et al. Use of a digital phantom developed by QIBA for harmonizing SUVs obtained from the state-of-the-art SPECT/CT systems: a multicenter study. EJNMMI Res. 2017;7(1):53.
Article PubMed PubMed Central Google Scholar
Renaud JM et al. Site qualification and clinical interpretation standards for 99mTc-SPECT perfusion imaging in a multi-center study of MITNEC (Medical Imaging Trials Network of Canada). J Nucl Cardiol. 2021;28(6):2712–25.
Peters SMB et al. Towards standardization of absolute SPECT/CT quantification: a multi-center and multi-vendor phantom study. EJNMMI Phys. 2019;6(1):29
Dickson JC, et al. Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database. Eur J Nucl Med Mol Imaging. 2011;39(1):188–97.
Gregory RA, et al. Standardised quantitative radioiodine SPECT/CT Imaging for multicentre dosimetry trials in molecular radiotherapy. Phys Med Biol. 2019;64(24):245013.
Article CAS PubMed Google Scholar
Taprogge J et al. Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project. EJNMMI Phys. 2020;7(1):61.
Zimmerman BE, et al. Multizentrische Evaluierung der Genauigkeit und Präzision bei der Quantifizierung planarer Bildgebung und SPECT: Eine Phantomstudie der IAEA. Z Med Phys. 2017;27(2):98–112.
Peters SMB et al. Variability in lutetium-177 SPECT quantification between different state-of-the-art SPECT/CT systems. EJNMMI Phys. 2020;7(1):9.
Wevrett J, Fenwick A, Scuffham J, Nisbet A. Development of a calibration protocol for quantitative imaging for molecular radiotherapy dosimetry. Radiat Phys Chem. 2017;140(February):355–60.
Pacilio M, et al. The Italian multicentre dosimetric study for lesion dosimetry in 223Ra therapy of bone metastases: calibration protocol of gamma cameras and patient eligibility criteria. Phys Medica. 2016;32(12):1731–7.
Taprogge J, Wadsley J, Miles E, Flux GD. Recommendations for multicentre clinical trials involving dosimetry for molecular radiotherapy. Clin Oncol. 2021;33(2):131–6.
Gear JI, et al. EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations. Eur J Nucl Med Mol Imaging. 2018;45(13):2456–74.
Article CAS PubMed PubMed Central Google Scholar
Spick C, Herrmann K, Czernin J. 18 F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients. J Nucl Med. 2016;57:420–30.
Article CAS PubMed Google Scholar
Langbein T, Weber WA, Eiber M. Future of theranostics: an outlook on precision oncology in nuclear medicine. J Nucl Med. 2019;60(9):13S-19S.
留言 (0)